Michael Scolaro

Michael Scolaro

Sep 23, 2017

Group 6 Copy 254
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Mathematical model to reduce maternal and infant mortality in Southeast Asia

    Maternal and child mortality in Southeast Asian countries is still very high, especially in poor and rural...

    Can we biologically extend the range of human vision into the near infrared?

    We have developed a protocol to augment human sight to see into the near infrared range through human formation...

    Backer Badge Funded